Literature DB >> 6773689

[Abscence of chromosomes abnormalities and acute leukemia : relationships with normal bone marrow cells].

R Berger, A Bernheim, G Flandrin.   

Abstract

The absence of chromosome abnormalities in 50% of human acute leukemias stress the significance of cytogenetic abnormalities in malignancies. Karyotypically normal cells from acute leukemias were shown to be non leukemic cells by cytological and cytogenetic comparisons. Chromosomally normal acute promyelocytic leukemias could be explained by differences between proliferation rates of bone marrow cells and by bias when choosing metaphases to be analysed. The role of chromosomal abnormalities in acute leukemia must be therefore questioned from a new definition of cytogenetic methods.

Entities:  

Mesh:

Year:  1980        PMID: 6773689

Source DB:  PubMed          Journal:  C R Seances Acad Sci D        ISSN: 0567-655X


  5 in total

1.  No chromosome arm unturned: in memory of Roland Berger 1934-2012.

Authors:  C J Harrison; J D Rowley; H Van den Berghe; A Bernheim; M Martineau; M Gautier; M Le Coniat-Busson; S Romana; N Dastugue; A Hagemeijer; P Jonveaux; F Nguyen-Khac; O A Bernard
Journal:  Leukemia       Date:  2014-02       Impact factor: 11.528

2.  Direct versus cultured preparation of bone marrow cells from 22 patients with acute myeloid leukemia.

Authors:  P H Fitzgerald; C M Morris; L M Giles
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Cytogenetic study in acute myeloid leukaemia using peripheral blood samples sent by post.

Authors:  Y S Li; F G Hayhoe
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

Review 4.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

5.  Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL).

Authors:  D Sheer; T A Lister; J Amess; E Solomon
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.